Cardiac resynchronization with adaptive A1-A2 and/or V1-V2 intervals
Patent 6839592 Issued on January 4, 2005. Estimated Expiration Date: 
April 22, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
April 22, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesImplantable cardiac stimulation device and method which optimizes pacing effectiveness Patent #: 6567700 InventorAssigneeApplicationNo. 10126516 filed on 04/22/2002US Classes:607/9, Heart rate regulating (e.g., pacing)607/14Treating or preventing abnormally high heart rateExaminersPrimary: Sykes, Angela D.Assistant: Bradford, Roderick Attorney, Agent or FirmForeign Patent References
International ClassesA61N 136A61N 1368 A61N 137 A61N 137 A61N 1362 AbstractIn a system that provides bi-atrial and/or bi-ventricular pacing, the system adjusts an interval between paces delivered to the atria, and/or an interval between paces delivered to the ventricles, as a function of heart rate. By adjusting the interval between paces as a function of heart rate, the atria and/or ventricles may be activated in a more synchronous and more hemodynamically efficient fashion. | |
